CR11836A - IMMEDIATE DIAGNOSTIC TEST FOR DETECTION OF EXPOSURE OR IMMUNITY AGAINST DENGUE VIRUS - Google Patents

IMMEDIATE DIAGNOSTIC TEST FOR DETECTION OF EXPOSURE OR IMMUNITY AGAINST DENGUE VIRUS

Info

Publication number
CR11836A
CR11836A CR11836A CR11836A CR11836A CR 11836 A CR11836 A CR 11836A CR 11836 A CR11836 A CR 11836A CR 11836 A CR11836 A CR 11836A CR 11836 A CR11836 A CR 11836A
Authority
CR
Costa Rica
Prior art keywords
dengue virus
diagnostic test
exposure
immunity against
detection
Prior art date
Application number
CR11836A
Other languages
Spanish (es)
Inventor
Kumar Sil Bijon
yun ying Tan
Original Assignee
Mp Biomedicals Asia Pacific Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mp Biomedicals Asia Pacific Pte Ltd filed Critical Mp Biomedicals Asia Pacific Pte Ltd
Publication of CR11836A publication Critical patent/CR11836A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G01N2333/185—Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención provee una "prueba de diagnóstico inmediato" (PDCT) para detectar a un sujeto que ha estado expuesto al virus del dengue o parte inmunológica del mismo o quien ha logrado algún nivel de inmunidad contra un antígeno del virus del dengue.The present invention provides an "immediate diagnostic test" (PDCT) for detecting a subject who has been exposed to dengue virus or immunological part thereof or who has achieved some level of immunity against a dengue virus antigen.

CR11836A 2008-05-15 2010-12-09 IMMEDIATE DIAGNOSTIC TEST FOR DETECTION OF EXPOSURE OR IMMUNITY AGAINST DENGUE VIRUS CR11836A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG200803904-2A SG157244A1 (en) 2008-05-15 2008-05-15 Point of care test for the detection of exposure or immunity to dengue virus

Publications (1)

Publication Number Publication Date
CR11836A true CR11836A (en) 2011-06-07

Family

ID=41318932

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11836A CR11836A (en) 2008-05-15 2010-12-09 IMMEDIATE DIAGNOSTIC TEST FOR DETECTION OF EXPOSURE OR IMMUNITY AGAINST DENGUE VIRUS

Country Status (7)

Country Link
BR (1) BRPI0915291A2 (en)
CO (1) CO6311040A2 (en)
CR (1) CR11836A (en)
EC (1) ECSP10010680A (en)
MX (1) MX2010012363A (en)
SG (1) SG157244A1 (en)
WO (1) WO2009139725A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG165194A1 (en) * 2009-03-20 2010-10-28 Mp Biomedicals Asia Pacific Pte Ltd Point of care test for the detection of exposure to hev immunoglobulin a (iga)
CN102393454A (en) * 2011-08-24 2012-03-28 中国检验检疫科学研究院 Colloidal gold test strip for detecting dengue virus antibody and preparation method and application thereof
PE20211814A1 (en) 2013-03-15 2021-09-14 Takeda Vaccines Inc COMPOSITIONS AND METHODS OF CHEMERICAL CONSTRUCTION OF DENGUE VIRUS IN VACCINES
SG10201404571PA (en) * 2014-08-01 2016-03-30 Mp Biomedicals Asia Pacific Pte Ltd Method and kit for detecting a dengue virus infection
MX2021002586A (en) 2018-09-05 2021-06-08 Takeda Vaccines Inc Dengue vaccine unit dose and administration thereof.
US11464815B2 (en) 2018-09-05 2022-10-11 Takeda Vaccines, Inc. Dengue vaccine unit dose and administration thereof
WO2021202992A2 (en) * 2020-04-03 2021-10-07 Lawrence Loomis Rapid point of care assay for the detection of the asymptomatic carrier state of covid-19
US20230204574A1 (en) * 2020-04-24 2023-06-29 Massachusetts Institute Of Technology Rapid, point of care detection of neutralizing antibodies against a virus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03148066A (en) * 1989-11-06 1991-06-24 Nippon Zeon Co Ltd Membrane for diagnosing virus infectious disease and diagnostic method
WO1999006068A2 (en) * 1997-07-31 1999-02-11 Hawaii Biotechnology Group, Inc. Recombinant dimeric envelope vaccine against flaviviral infection
FR2767324B1 (en) * 1997-08-14 2001-04-06 Pasteur Institut USE OF RECOMBINANT ENVELOPE PROTEINS FOR THE DIAGNOSIS OF DENGUE VIRUS
WO2005014627A1 (en) * 2003-08-07 2005-02-17 International Centre For Genetic Engineering And Biotechnology Recombinant dengue multi epitope proteins as diagnostic intermediates
SG137711A1 (en) * 2006-05-11 2007-12-28 Nat Environment Agency Antigen capture anti-dengue iga elisa (aca-elisa) for the detection of a flavivirus specific antibody

Also Published As

Publication number Publication date
SG157244A1 (en) 2009-12-29
CO6311040A2 (en) 2011-08-22
MX2010012363A (en) 2011-04-11
ECSP10010680A (en) 2011-04-29
WO2009139725A1 (en) 2009-11-19
BRPI0915291A2 (en) 2016-02-16

Similar Documents

Publication Publication Date Title
CR11836A (en) IMMEDIATE DIAGNOSTIC TEST FOR DETECTION OF EXPOSURE OR IMMUNITY AGAINST DENGUE VIRUS
CO6551725A2 (en) DEVICE FOR THE IDENTIFICATION OF ORAL AFFECTIONS
BR112013033418A2 (en) Method and apparatus for testing drug offenders
BR112015022763A8 (en) sensor to detect an analyte
BR112012030552A2 (en) immunogenic composition
BR112014013082A2 (en) method for detecting nucleosome adducts
CO6160335A2 (en) VACCINE
ATE493290T1 (en) ALCOTEST DEVICE
TW200740840A (en) Diagnostic test kits
TR201904386T4 (en) Method for detecting nucleosomes containing nucleotides.
BR112015023421A2 (en) ground-based wind turbine blade inspection method and system
CO6690763A2 (en) Myostatin specific antibody and compositions containing it
BR112014012174A2 (en) method, device, and data frame for spectrum detection
BR112013023540A2 (en) antibody, kit and method for determination of amyloid peptides
EP2078083A4 (en) A novel canine influenza virus and vaccine therefore
NO20082257L (en) Influenza virus that can infect canids
BR112015001414A2 (en) antiderive composition
DOP2011000268A (en) DENGUE VIRUS INACTIVATED VACCINE WITH AN ALUMINUM FREE ADJUVANT
CY1115437T1 (en) Hydroxymethylcyclohexylamines
CO6761296A2 (en) Detection method
BR112013001060A2 (en) detection device
DK2396652T3 (en) DIAGNOSIS OF INFLAMMATORY GAS SYNDROME BASED ON CYTOLETALLY EFFECTIVE TOXIN
CY1116083T1 (en) METHOD FOR DETERMINING TYPES OF HUMAN PATIENTS (HPV)
ES2723710T3 (en) System and method for a reference pressure test
CL2011003043A1 (en) Composition for protecting subject against dengue virus serotype comprising at least two dengue virus serotypes; system for administering a dengue vaccine composition; vaccine kit because it comprises at least one dengue virus vaccine composition.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)